Navigation Links
Experts Explore Federal Agency Collaborations to Close Alzheimer’s Disease Research Gaps at ACT-AD Coalition Annual Meeting
Date:11/16/2016

Today, senior representatives from the U.S. Food and Drug Administration (FDA) and the National Institute on Aging (NIA) at the National Institutes of Health (NIH) joined with advocates, federal colleagues, researchers, and industry to explore collaborations for advancing the most up-to-date knowledge in Alzheimer’s disease research into clinical trials at the ACT-AD Coalition's Ninth Annual FDA/Alzheimer’s Disease Allies Meeting in North Bethesda, Md.

The theme of this year’s meeting was "Starting with the End in Mind: Aligning the Science to Close Gaps in Alzheimer’s Disease Therapeutic Development."

“Our 2015 ACT-AD meeting focused on the state of research, including existing gaps, into the underlying causes of Alzheimer’s disease and the pathways for successful treatment. This year, we picked up where that meeting left off,” says ACT-AD Executive Director Cynthia Bens. “At our meeting today, attendees held a frank discussion on whether NIH research is on track to help definitively close knowledge gaps identified by the FDA that will promote more successful therapeutic development. The consensus is that we have made significant strides, but we need to continue to refine strategies that increase research collaborations between government agencies, researchers, advocates, and industry. We look forward to continuing to build on the progress we made today.”

The main areas of focus at the meeting included: the most recent research on Alzheimer’s disease pathology and genetics; efforts to identify reliable biomarkers in treatment trials and advance novel biomarkers; and symptomatic approaches to improve treatment of major behavioral and psychiatric aspects of the disease.

The meeting featured a trio of expert presentations:

  • NIH Initiatives to Inform Alzheimer’s Disease Therapeutic Development, Richard Hodes, M.D., National Institute on Aging
  • Genetic and Biomarker Advances from Clinical Trials in Early Alzheimer’s Disease, Carole Ho, M.D., Denali, and Vissia Viglietta, M.D., Ph.D., Biogen
  • Findings from Current Trials Treating Behavioral and Psychiatric Symptoms of Alzheimer’s Disease, Paul Rosenberg, M.D., Johns Hopkins University

Also, a distinguished panel of experts explored the scientific and regulatory considerations for developing meaningful disease-modifying and symptomatic Alzheimer’s disease treatments.

ACT-AD and its partners will provide a more detailed summary of the results of today’s meeting at a future date. For more information, please visit the coalition’s meeting webpage or call 202-688-1229.

About ACT-AD

ACT-AD is a coalition of more than 50 national organizations representing patients, providers, caregivers, consumers, older Americans, researchers, and employers seeking to accelerate development of potential cures and treatments for Alzheimer's disease. The coalition is directed by an Advisory Council made up of representatives from the Alliance for Aging Research (AAR), Alzheimer's Foundation of America (AFA), American Society on Aging (ASA), National Alliance for Caregiving (NAC), National Association of Area Agencies on Aging (n4a), National Consumers League (NCL), Research!America, and the Society for Women's Health Research. The coalition is sponsored in part by Alkermes, Anavex, Avanir, Axovant, Biogen Idec, Eli Lilly, Genentech, Janssen, Lundbeck, Merck, and Novartis.

Read the full story at http://www.prweb.com/releases/2016/11/prweb13854721.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Salar Joins Medical Informatics Experts to Judge AMIA’s First Ever Student Design Challenge: Reinventing Clinical Documentation
2. Sublime Beauty® Reveals the "Work-Horse" of Anti-Aging Skin Care According to Dermatologists and Experts
3. Heartland Institute Experts React to President Obama’s Announcement about the Affordable Care Act
4. Medical Experts Gather at Cleveland Clinic Lou Ruvo Center for Brain Health for Annual Silverado Medical Director Conference
5. As a Record Number of Seniors Are Living Alone, Aging Experts Offer 7 Warning Signs to Look for on Thanksgiving Visits to Older Family Members and Friends
6. Noted Experts to Lead Breakthrough Conversation at Center for Hispanic Leadership, December 2nd Hispanics in Healthcare Forum
7. The Dentist's Network Launches New Website and Expands Panel of Experts
8. Tufts experts named Fellows by American Association for the Advancement of Science
9. Quality of Healthcare Experts Continue To Try To Put A Square Peg Into A Round Hole
10. Nutrition experts explore dietary approaches that influence type 2 diabetes risk
11. Pediatric HIV/AIDS experts to present at 17th Intl Conference on AIDS and STIs in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... St. Louis, Missouri (PRWEB) , ... August 18, 2017 , ... ... ” says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To ... way they help children learn social and emotional skills, she created the Time-In Toolkit, ...
(Date:8/18/2017)... ... August 18, 2017 , ... With ... specializing in bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner ... of aging, such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , ...
(Date:8/18/2017)... ... 18, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... on false teachings pertaining to the mother of the Savior whom the world calls “Mother ... different picture of the role of this historical woman. , “The world bows, kisses ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that ... its marketing efforts with its product now available through Jet.com. , After 25 ... The effervescent powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced ...
(Date:8/18/2017)... CA & CARMEL, IN (PRWEB) , ... August 18, 2017 , ... ... on its 36th annual list, the most prestigious ranking of the nation's fastest-growing private ... been included in the exclusive Inc. 5000 ranking . This year’s ranking reflects ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... 17, 2017 MJAC2017 , the premier cannabis ... Media, today reveals its leading lineup. MJAC2017 ... global cannabis innovator specializing in the development of pharmaceutical and ... MassRoots, Rambridge™ and The Green Organic Dutchman are gold sponsors ... Vapes™ as silver sponsors. ...
(Date:8/17/2017)... August 17, 2017 DarioHealth Corp. (NASDAQ: ... mobile health and big data solutions, announced today ... domestic and non-U.S. investors for the sale of ... of the Company,s newly designated Series B Convertible ... Company expects to conduct a closing with respect ...
(Date:8/17/2017)... LLC Chief Science Officer, Dr. Adam Elhofy , will be discussing ... Universal Titer Boost at the 9 th annual Bioprocessing ... Bioprocessing Summit convenes more than 1,000 international bioprocess professionals to share practical ... Cell-Ess Universal ... Cell-Ess is the world,s first ...
Breaking Medicine Technology: